ArticleCell death & disease2022

Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax.

Damjan Avsec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.